AUDIOEYE INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AUDIOEYE INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.31M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $35.20M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $31.32M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $29.91M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $24.50M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $20.48M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $10.77M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $5.66M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $2.74M | Mar 27, 2019 |
| FY2015 | Dec 31, 2015 | $338.9K | Mar 30, 2016 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.74M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $994.3K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $338.9K | Mar 30, 2017 |
| FY2015 | Dec 31, 2014 | $516.8K | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $1.45M | Jul 10, 2015 |
| FY2013 | Dec 31, 2012 | $279.1K | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $125.5K | Apr 15, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.56M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $27.94M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $24.34M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $22.69M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $18.38M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $14.51M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $6.36M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $3.03M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $1.36M | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | ($232.1K) | Apr 2, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.08M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($4.25M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($5.87M) | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | ($10.43M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($14.21M) | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | ($7.16M) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($7.78M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | ($5.02M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($5.61M) | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | ($9.58M) | Apr 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.83M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($3.39M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($5.97M) | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | ($10.43M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($15.51M) | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | ($7.13M) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($7.82M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | ($4.57M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($4.52M) | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | ($4.48M) | Apr 2, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.59M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $5.08M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $6.99M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $6.09M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $5.30M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $1.23M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $636.0K | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $194.4K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $181.3K | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $343.7K | Apr 2, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.75M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.73M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $318.0K | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | ($5.00M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($4.98M) | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | ($1.91M) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($5.62M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | ($1.64M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($1.62M) | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | ($2.34M) | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.0K | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $128.0K | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $171.0K | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $72.0K | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $82.0K | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $56.0K | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $10.9K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $41.2K | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $0 | Apr 2, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.23M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $29.77M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $25.50M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $24.43M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $29.31M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $18.25M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $9.15M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $9.10M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $5.03M | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $4.49M | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.43M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $20.33M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $18.79M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $13.84M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $11.72M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $10.62M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $7.59M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $3.23M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $4.34M | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $4.18M | Apr 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.80M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $9.44M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $6.71M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $10.59M | Mar 12, 2025 |
| FY2023 | Dec 31, 2021 | $17.60M | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | $7.63M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $1.57M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $5.88M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $696.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $307.2K | Mar 27, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.68M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $6.66M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $4.00M | Mar 12, 2026 |
| FY2023 | Dec 31, 2022 | $4.00M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $701.0K | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $701.0K | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $701.0K | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $700.5K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $700.5K | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $700.5K | Apr 2, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($103.40M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($95.75M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($89.48M) | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | ($82.48M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($71.29M) | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | ($57.08M) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($49.93M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | ($42.14M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($39.43M) | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | ($33.82M) | Apr 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.29M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $5.65M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $9.24M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | $6.90M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $18.97M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $9.10M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $1.97M | Mar 11, 2021 |
| FY2020 | Dec 31, 2018 | $5.74M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $1.96M | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $1.41M | Mar 27, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.40M | Mar 12, 2026 |
| FY2016 | Dec 31, 2016 | $0 | Mar 30, 2017 |
| FY2016 | Dec 31, 2015 | $1.92M | Mar 30, 2017 |
| FY2015 | Dec 31, 2014 | $51.8K | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $79.8K | Jul 10, 2015 |
| FY2013 | Dec 31, 2012 | $97.8K | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $121.8K | Apr 15, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 11, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 11, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.38M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 12.29M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 11.71M | Mar 12, 2025 |
| FY2023 | Dec 31, 2022 | 11.55M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 11.44M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | 10.13M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | 8.88M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | 7.58M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 6.47M | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | 111.51M | Apr 2, 2018 |